RESUMEN
BACKGROUND: Synthetic and natural antioxidants including Bacopa monnieri (L.) Pennell (Scrophulariaceae) which also possess anti-dopaminergic properties, have been proposed to be useful for emetogenic chemotherapy. In this study, synthetic [N-(2-mercaptopropionyl) glycine (MPG), vitamin C (Vit-C)] and natural [grape seed proanthocyanidin (GP), B. monnieri n-butanolic fraction (BM-ButFr)] antioxidants and their combinations were evaluated against cisplatin-induced emesis in pigeons during a 24 h observation period. METHODS: Emesis was induced using cisplatin (7.0 mg/kg, i.v). MPG (10, 20, 30 mg/kg), Vit-C (100, 200, 300 mg/kg), GP (50, 100, 150 mg/kg) and BM-ButFr (5, 10, 20 mg/kg) and their combinations were administered i.m., 15 min before cisplatin administration. The number of vomiting bouts, retching, emetic latency and % weight loss were recorded to assess antiemetic potential. Antioxidant activity was evaluated by the DPPH free radical scavenging assay (FRSA). RESULTS: Significant attenuation of vomiting bouts, retching, % weight loss along with an increase in latency was produced by all the antioxidants and their combinations compared to cisplatin alone and this is the first report of this activity of GP in pigeons. Low EC50 values in the FRSA for MPG (67.66 µg/mL), Vit-C (69.42 µg/mL), GP (6.498 µg/mL) and BM-ButFr (55.61 µg/mL) compared to BHT standard (98.17 µg/mL) demonstrated their radical scavenging capacity. Correlation between the antioxidant activity and antiemetic efficacy disclosed a high degree of correlation for the tested antioxidants. CONCLUSION: The selected synthetic and natural antioxidants and their combinations were able to attenuate cisplatin-induced vomiting, which correlated with their potent in vitro antioxidant activity.
Asunto(s)
Antioxidantes/uso terapéutico , Cisplatino/toxicidad , Extractos Vegetales/uso terapéutico , Vómitos/inducido químicamente , Vómitos/tratamiento farmacológico , Animales , Antieméticos/aislamiento & purificación , Antieméticos/uso terapéutico , Antineoplásicos/toxicidad , Antioxidantes/aislamiento & purificación , Ácido Ascórbico/aislamiento & purificación , Ácido Ascórbico/uso terapéutico , Bacopa , Columbidae , Femenino , Extracto de Semillas de Uva/aislamiento & purificación , Extracto de Semillas de Uva/uso terapéutico , Masculino , Extractos Vegetales/aislamiento & purificación , Proantocianidinas/aislamiento & purificación , Proantocianidinas/uso terapéutico , Tiopronina/aislamiento & purificación , Tiopronina/uso terapéuticoRESUMEN
Nausea and vomiting is the common problem disturbing almost 80% of the females in initial three months of conception and later sometime throughout pregnancy. To find out the efficacy and safety of herbal coded test drug Gingocap in comparison with the control drug Pyridoxine, a randomized clinical case control study was conducted at the OPD of Yusra Medical Centre, Karachi and Amir Habib Medical Center and Maternity Home, Karachi. After administration of test and control drug the frequency of nausea and vomiting was noted after every 2 weeks on 2nd, 4th, 6th and 8th weeks during 60 days of the course of study. The percentage of reduction of nausea and vomiting symptoms from the baseline in cases treated with test Gingocap compared to control drug Pyridoxine was recorded. Overall 35 and 30 patients were administered Gingocap and Pyridoxine between 6-16 weeks conception respectively. The data analyzed through T-test using SPSS version 18.0. It was concluded that Gingocap has the potential to relieve the symptoms of nausea and vomiting and exhibited no side effects and this drug was acceptable by maximum number of the patients.
Asunto(s)
Antieméticos/uso terapéutico , Náuseas Matinales/prevención & control , Extractos Vegetales/uso terapéutico , Piridoxina/uso terapéutico , Zingiber officinale/química , Adulto , Anciano , Antieméticos/efectos adversos , Antieméticos/aislamiento & purificación , Femenino , Humanos , Persona de Mediana Edad , Náuseas Matinales/diagnóstico , Pakistán , Fitoterapia , Extractos Vegetales/efectos adversos , Extractos Vegetales/aislamiento & purificación , Plantas Medicinales , Embarazo , Piridoxina/efectos adversos , Rizoma/química , Factores de Tiempo , Resultado del TratamientoRESUMEN
Ginger (Zingiber officinale) is a spice traditionally used to treat indigestion, nausea and vomiting. Ginger extracts accelerate gastric emptying and stimulate gastric antral contractions. These effects are mainly due to the presence of gingerols and shogaols and their activity on cholinergic M receptors and serotonergic 5-HT and 5-HT receptors. Various researches on this subject have led to controversial results, due to the chemical instability of ginger extracts and particularly of gingerols, which are readily-oxidizable substances. A systematic review of double-blind, placebo-controlled, randomized studies highlighted the potential efficacy of ginger on the prevention and treatment of nausea and vomiting of various origins, even though additional controlled studies are needed. This review focuses on pregnancy-induced nausea and vomiting and on chemotherapy induced nausea, and hypothesizes a therapeutic role for ginger extracts in case of side effects, as an alternative to traditional prokinetic drugs such as domperidone, levosulpiride or metoclopramide.
Asunto(s)
Antieméticos/uso terapéutico , Náusea/tratamiento farmacológico , Extractos Vegetales/uso terapéutico , Complicaciones del Embarazo/tratamiento farmacológico , Vómitos/tratamiento farmacológico , Zingiber officinale , Animales , Antieméticos/aislamiento & purificación , Antieméticos/farmacología , Antineoplásicos/efectos adversos , Catecoles/aislamiento & purificación , Catecoles/farmacología , Catecoles/uso terapéutico , Alcoholes Grasos/aislamiento & purificación , Alcoholes Grasos/farmacología , Alcoholes Grasos/uso terapéutico , Femenino , Vaciamiento Gástrico/efectos de los fármacos , Humanos , Náusea/inducido químicamente , Náusea/diagnóstico , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/farmacología , Embarazo , Complicaciones del Embarazo/diagnóstico , Vómitos/inducido químicamente , Vómitos/diagnósticoRESUMEN
PURPOSE: Despite the widespread use of antiemetics, nausea continues to be reported by over 70% of patients receiving chemotherapy. METHODS: In this double blind, multicenter trial, we randomly assigned 744 cancer patients to four arms: 1) placebo, 2) 0.5 g ginger, 3) 1.0 g ginger, or 4) 1.5 g ginger. Nausea occurrence and severity were assessed at a baseline cycle and the two following cycles during which patients were taking their assigned study medication. All patients received a 5-HT(3) receptor antagonist antiemetic on Day 1 of all cycles. Patients took three capsules of ginger (250 mg) or placebo twice daily for 6 days starting 3 days before the first day of chemotherapy. Patients reported the severity of nausea on a 7-point rating scale ("1" = "Not at all Nauseated" and "7" = "Extremely Nauseated") for Days 1-4 of each cycle. The primary outcomes were to determine the dose and efficacy of ginger at reducing the severity of chemotherapy-induced nausea on Day 1 of chemotherapy. RESULTS: A total of 576 patients were included in final analysis (91% female, mean age = 53). Mixed model analyses demonstrated that all doses of ginger significantly reduced acute nausea severity compared to placebo on Day 1 of chemotherapy (p = 0.003). The largest reduction in nausea intensity occurred with 0.5 g and 1.0 g of ginger (p = 0.017 and p = 0.036, respectively). Anticipatory nausea was a key factor in acute chemotherapy-induced nausea (p < 0.0001). CONCLUSIONS: Ginger supplementation at a daily dose of 0.5 g-1.0 g significantly aids in reduction of the severity of acute chemotherapy-induced nausea in adult cancer patients.
Asunto(s)
Antieméticos/uso terapéutico , Náusea/prevención & control , Fitoterapia , Vómitos/prevención & control , Zingiber officinale/química , Antieméticos/administración & dosificación , Antieméticos/aislamiento & purificación , Antineoplásicos/efectos adversos , Antineoplásicos/uso terapéutico , Relación Dosis-Respuesta a Droga , Método Doble Ciego , Femenino , Humanos , Masculino , Persona de Mediana Edad , Náusea/inducido químicamente , Neoplasias/tratamiento farmacológico , Antagonistas del Receptor de Serotonina 5-HT3/uso terapéutico , Índice de Severidad de la Enfermedad , Resultado del Tratamiento , Vómitos/inducido químicamente , Vómito Precoz/prevención & controlRESUMEN
RATIONALE: The interaction between two non-psychotropic cannabinoids, cannabidiol (CBD) and cannabigerol (CBG), which have been reported to act as a 5-hydroxytryptamine 1A (5-HT(1A)) agonist and antagonist, respectively, was evaluated. OBJECTIVE: To evaluate the potential of CBG to reverse the anti-nausea, anti-emetic effects of CBD. MATERIALS AND METHODS: In experiment 1, rats were pre-treated with CBG (0.0, 1, 5, and 10 mg/kg, ip), 15 min prior to being treated with CBD (experiment 1a: VEH or 5 mg/kg, ip) or 8-OH-DPAT (experiment 1b: VEH or 0.01 mg/kg, ip). Thirty minutes later, all rats received a pairing of 0.1% saccharin solution and LiCl (20 ml/kg of 0.15 M, ip). Seventy-two hours later, the rats received a drug-free taste reactivity test with saccharin to evaluate the effects of the treatments on the establishment of conditioned gaping reactions (a model of nausea). As well, conditioned saccharin avoidance was measured. In experiment 2, Suncus murinus were injected with CBG (5 mg/kg, ip) or VEH 15 min prior to CBD (5 mg/kg) or VEH and 30 min later were injected with LiCl (60 ml/kg of 0.15 M, i.p.), and the number of vomiting episodes were measured. RESULTS: CBD (5 mg/kg) suppressed conditioned gaping in rats and vomiting in shrews, which were reversed by pre-treatment with all doses of CBG. CBG also prevented the anti-nausea effects of 8-OH-DPAT. CONCLUSIONS: Interactions between moderate doses of CBG and CBD may oppose one another at the 5-HT(1A) receptor in the regulation of nausea and vomiting.
Asunto(s)
Antieméticos/farmacología , Cannabidiol/farmacología , Cannabinoides/farmacología , Cannabis/química , 8-Hidroxi-2-(di-n-propilamino)tetralin/farmacología , Animales , Antieméticos/administración & dosificación , Antieméticos/aislamiento & purificación , Reacción de Prevención/efectos de los fármacos , Cannabidiol/administración & dosificación , Cannabidiol/aislamiento & purificación , Cannabinoides/administración & dosificación , Cannabinoides/aislamiento & purificación , Relación Dosis-Respuesta a Droga , Interacciones Farmacológicas , Masculino , Ratas , Ratas Sprague-Dawley , Sacarina/administración & dosificación , Agonistas del Receptor de Serotonina 5-HT1/administración & dosificación , Agonistas del Receptor de Serotonina 5-HT1/aislamiento & purificación , Agonistas del Receptor de Serotonina 5-HT1/farmacología , Antagonistas del Receptor de Serotonina 5-HT1/administración & dosificación , Antagonistas del Receptor de Serotonina 5-HT1/aislamiento & purificación , Antagonistas del Receptor de Serotonina 5-HT1/farmacología , MusarañasRESUMEN
OBJECTIVES: Gastrointestinal (GI) side effects such as nausea and vomiting are common following opioid analgesia and represent a significant cause of patient discomfort and treatment dissatisfaction. This review examines the mechanisms that produce these side effects, their impact on treatment outcomes in chronic pain patients, and counteractive strategies. RESULTS: A number of mechanisms by which opioids produce nausea and vomiting have been identified. These involve both central and peripheral sites including the vomiting center, chemoreceptor trigger zones, cerebral cortex, and the vestibular apparatus of the brain, as well as the GI tract itself. Nausea and vomiting have a negative impact on treatment efficacy and successful patient management because they limit the effective analgesic dosage that can be achieved and are frequently reported as the reason for discontinuation of opioid pain medication or missed doses. While various strategies such as antiemetic agents or opioid switching can be employed to control these side effects, neither option is ideal because they are not always effective and incur additional costs and inconvenience. Opioid-sparing analgesic agents may provide a further alternative to avoid nausea and vomiting due to their reduced reliance on mu-opioid signalling pathways to induce analgesia. CONCLUSIONS: Nausea and vomiting side effects limit the analgesic efficiency of current opioid therapies. There is a clear need for the development of improved opioid-based analgesics that mitigate these intolerable effects.
Asunto(s)
Analgésicos Opioides/efectos adversos , Antieméticos/aislamiento & purificación , Náusea/inducido químicamente , Dolor Intratable/tratamiento farmacológico , Vómitos/inducido químicamente , Antieméticos/uso terapéutico , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Encéfalo/fisiopatología , Humanos , Náusea/tratamiento farmacológico , Náusea/fisiopatología , Vías Nerviosas/efectos de los fármacos , Vías Nerviosas/metabolismo , Vías Nerviosas/fisiopatología , Cooperación del Paciente/psicología , Receptores Opioides/efectos de los fármacos , Receptores Opioides/metabolismo , Vómitos/tratamiento farmacológico , Vómitos/fisiopatologíaRESUMEN
Bioasay-guided fractionation of the antiemetic constituents of Alpinia officinarum was performed, and eight compounds (1-8) including a new compound were isolated. Among the seven known compounds, two flavonoids (1, 2), four diarylheptanoids (3, 5, 6, 8), and one sterol (4) were obtained, with five (2-6) of those compounds showing antiemetic activity in a copper sulfate induced emesis assay in young chicks. The structure of the new compound 7, which also showed antiemetic activity, was determined as 5-hydroxy-7-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-3-heptanone. The structure of 7 was established on the basis of spectroscopic data interpretation.
Asunto(s)
Antieméticos/aislamiento & purificación , Diarilheptanoides/aislamiento & purificación , Medicamentos Herbarios Chinos/aislamiento & purificación , Flavonoides/aislamiento & purificación , Plantas Medicinales/química , Zingiberales/química , Animales , Antieméticos/química , Antieméticos/farmacología , Pollos , Cromatografía Líquida de Alta Presión , Sulfato de Cobre/farmacología , Diarilheptanoides/química , Diarilheptanoides/farmacología , Medicamentos Herbarios Chinos/química , Medicamentos Herbarios Chinos/farmacología , Flavonoides/química , Flavonoides/farmacología , Japón , Masculino , Conformación Molecular , Estructura Molecular , Resonancia Magnética Nuclear Biomolecular , Fitosteroles/química , Fitosteroles/aislamiento & purificación , Fitosteroles/farmacología , Rizoma , EstereoisomerismoRESUMEN
A novel experimental model of free radical-induced emesis for screening anti-emetic compounds from natural sources was established. 2,2'-Azobis(2-amidinopropane) dihydrochloride (AAPH) dissolved in liposome induced emesis in young chickens, and the emesis was prevented by antioxidants including N-(2-mercaptopropionyl)-glycine (MPG), alpha-tocopherol, and L-ascorbic acid. Tropiseton, a serotonin receptor antagonist, also prevented emesis induced by AAPH. Known anti-emetic drugs and anti-emetic principles from natural sources also showed significant retching inhibition in the experiment using this system.
Asunto(s)
Antieméticos/farmacología , Antioxidantes/farmacología , Plantas Medicinales , Vómitos/prevención & control , Amidinas , Animales , Antieméticos/aislamiento & purificación , Pollos , Evaluación Preclínica de Medicamentos/métodos , Radicales Libres , Liposomas , Masculino , Oxidantes , Vómitos/inducido químicamenteRESUMEN
Two novel diarylheptanoids named katsumadain A (1) and katsumadain B (2) were isolated from the seeds of Alpinia katsumadai, and their structures were determined by spectroscopic analysis. Both katsumadains A (1) and B (2) showed anti-emetic activities on copper sulfate-induced emesis in young chicks.
Asunto(s)
Antieméticos/aislamiento & purificación , Diarilheptanoides , Medicamentos Herbarios Chinos/aislamiento & purificación , Pironas/aislamiento & purificación , Zingiberales/química , Animales , Pollos , Modelos Químicos , Semillas/químicaRESUMEN
Magnolol and honokiol, biphenyl compounds, were isolated as anti-emetic principles from the methanolic extract of Magnolia obovata bark. [6]-, [8]-, and [10]-shogaols and [6]-, [8]-, and [10]-gingerols were isolated from the methanolic extract of Zingiber officinale rhizome as anti-emetic principles. Some phenyl-propanoids with allyl side-chains were found to show the same activity. They inhibited the emetic action induced by the oral administration of copper sulfate pentahydrate to leopard and ranid frogs.